CTOs on the Move

ManageSoft Corporation

www.managesoft.com

 
ManageSoft Corporation is a Boston, MA-based company in the Software and Internet sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Sphere Technical Resources

Sphere Technical Resources is a Raleigh, NC-based company in the Software and Internet sector.

Wagepoint

Wagepoint is a fintech company on a mission to simplify payroll – and maybe even dare to make it delightful! Our online software was created just for small businesses, automating the most time-consuming parts of payroll – like calculating wages and reporting on taxes – so that our customers can get back to doing what they love most. Backed by the world`s friendliest team, Wagepoint is always supportive, never stuffy and refreshingly human. Founded in 2012, we make payroll magic happen for more than 18,000 small businesses, accountants and bookkeepers across North America.

Glean AI

Glean AI is Intelligent AP. We leverage untapped invoice data to surface relevant context, actionable insights, and savings recommendations that power great spend decisions.

Hosted Data Transaction Solutions Inc

Hosted Data Transaction Solutions Inc is a Toronto, ON-based company in the Software and Internet sector.

Cypher Genomics

Cypher Genomics is a leading genome informatics company offering a highly accurate, rapid and robust interpretation software solution for users of human genome sequencing. The proprietary, automated genomic interpretation platform allows clinical laboratories to tune Cypher Genomics' market leading sensitivity and specificity profiles to develop molecular tests for diagnostic and prognostic use, and pharmaceutical companies to discover biomarkers from whole genome sequence data in sample sizes typical of early stage drug development studies. Through Mantis™, the genome interpretation software as a service offering, and Coral™, a biomarker discovery service, Cypher Genomics can improve health care and reduce costs by facilitating improved diagnostic accuracy and earlier interventions, optimizing therapeutic approaches and reducing adverse drug reactions. The gap between the ability to generate whole genome sequences at scale and the primarily manual process of interpretation to date creates a significant unmet need that is well served by the Cypher Genomics solution.